Oseltamivir resistance
Evolution of the Influenza A Virus Genome during Development of Oseltamivir Resistance In Vitro
10
Highly Sensitive and Quantitative Detection of the H274Y Oseltamivir Resistance Mutation in Seasonal A/H1N1 Influenza Virus
8
Five years of monitoring for the emergence of oseltamivir resistance in patients with influenza A infections in the Influenza Resistance Information Study (IRIS)
12
Identification of Oseltamivir Resistance among Pandemic and Seasonal Influenza A (H1N1) Viruses by an His275Tyr Genotyping Assay Using the Cycling Probe Method
6
NA segment to detect Oseltamivir-resistance,
6
Functional and Structural Analysis of Influenza Virus Neuraminidase N3 Offers Further Insight into the Mechanisms of Oseltamivir Resistance
9
Development of a quadruple qRT PCR assay for simultaneous identification of highly and low pathogenic H7N9 avian influenza viruses and characterization against oseltamivir resistance
9
Published sequences do not support transfer of oseltamivir resistance mutations from avian to human influenza A virus strains
7
Adamantane and Oseltamivir Resistant Seasonal A (H1N1) and Pandemic A (H1N1) 2009 Influenza Viruses in Guangdong, China, during 2008 and 2009
5
A two year survey of the oseltamivir resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir
8
Influenza Antiviral Resistance Testing in New York and Wisconsin, 2006 to 2008: Methodology and Surveillance Data
7
Resistance to Mutant Group 2 Influenza Virus Neuraminidases of an Oseltamivir-Zanamivir Hybrid Inhibitor
8
Efficacy of oseltamivir peramivir combination therapy compared to oseltamivir monotherapy for Influenza A (H7N9) infection: a retrospective study
8
Understanding the cross-resistance of oseltamivir to H1N1 and H5N1 influenza A neuraminidase mutations using multidimensional computational analyses
18
Oseltamivir in pregnancy and birth outcomes
10
Influenza treatment and prophylaxis with neuraminidase inhibitors: a review
12
Determination of Oseltamivir Phosphate in Capsules by Visible Spectrophotometry
5
Evaluation of Influenza A H1N1 infection and antiviral utilization in a tertiary care hospital
6
Prescription of antiviral drugs during the 2009 influenza pandemic: an observational study using electronic medical files of general practitioners in the Netherlands
7
Formulation and Evaluation of Oseltamivir Phosphate Capsules.
96